[HTML][HTML] Neuropathic pain: from mechanisms to treatment

NB Finnerup, R Kuner, TS Jensen - Physiological reviews, 2020 - journals.physiology.org
Neuropathic pain caused by a lesion or disease of the somatosensory nervous system is a
common chronic pain condition with major impact on quality of life. Examples include …

Galectin-3: one molecule for an alphabet of diseases, from A to Z

S Sciacchitano, L Lavra, A Morgante, A Ulivieri… - International journal of …, 2018 - mdpi.com
Galectin-3 (Gal-3) regulates basic cellular functions such as cell–cell and cell–matrix
interactions, growth, proliferation, differentiation, and inflammation. It is not surprising …

Allodynia and hyperalgesia in neuropathic pain: clinical manifestations and mechanisms

TS Jensen, NB Finnerup - The Lancet Neurology, 2014 - thelancet.com
Allodynia (pain due to a stimulus that does not usually provoke pain) and hyperalgesia
(increased pain from a stimulus that usually provokes pain) are prominent symptoms in …

Value of quantitative sensory testing in neurological and pain disorders: NeuPSIG consensus

N Attal, R Baron, D Bouhassira, M Drangholt, PJ Dyck… - PAIN®, 2013 - Elsevier
Quantitative sensory testing (QST) is a psychophysical method used to quantify
somatosensory function in response to controlled stimuli in healthy subjects and patients …

Neuropathic pain: a maladaptive response of the nervous system to damage

M Costigan, J Scholz, CJ Woolf - Annual review of neuroscience, 2009 - annualreviews.org
Neuropathic pain is triggered by lesions to the somatosensory nervous system that alter its
structure and function so that pain occurs spontaneously and responses to noxious and …

Spared nerve injury: an animal model of persistent peripheral neuropathic pain

I Decosterd, CJ Woolf - Pain, 2000 - journals.lww.com
Peripheral neuropathic pain is produced by multiple etiological factors that initiate a number
of diverse mechanisms operating at different sites and at different times and expressed both …

Animal models of pain: progress and challenges

JS Mogil - Nature Reviews Neuroscience, 2009 - nature.com
Many are frustrated with the lack of translational progress in the pain field, in which huge
gains in basic science knowledge obtained using animal models have not led to the …

Pain: moving from symptom control toward mechanism-specific pharmacologic management

CJ Woolf - Annals of internal medicine, 2004 - acpjournals.org
Pain: Moving from Symptom Control toward Mechanism-Specific Pharmacologic
Management | Annals of Internal Medicine Advertisement ACP Online Annals of Internal …

The therapeutic potential of interleukin-10 in neuroimmune diseases

AJ Kwilasz, PM Grace, P Serbedzija, SF Maier… - …, 2015 - Elsevier
Neuroimmune diseases have diverse symptoms and etiologies but all involve pathological
inflammation that affects normal central nervous system signaling. Critically, many …

Quantitative sensory testing: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

ME Shy, EM Frohman, YT So, JC Arezzo… - Neurology, 2003 - AAN Enterprises
Objective: This assessment evaluates the clinical utility, efficacy, and safety of quantitative
sensory testing (QST). Methods: By searching MEDLINE, Current Contents, and their …